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Autophagy is one of two major degradation systems in eukaryotic cells. The degradation mechanism of
autophagy is required to maintain the balance between the biosynthetic and catabolic processes and also
contributes to defense against invading pathogens. Recent studies suggest that a number of viruses can evade
or subvert the host cell autophagic pathway to enhance their own replication. Here, we investigated the effect
of autophagy on the KSHV (Kaposi’s sarcoma-associated herpesvirus) life cycle. We found that the inhibition
of autophagy reduces KSHV lytic reactivation from latency, and an enhancement of autophagy can be detected
during KSHV lytic replication. In addition, RTA (replication and transcription activator), an essential viral
protein for KSHV lytic reactivation, is able to enhance the autophagic process, leading to an increase in the
number of autophagic vacuoles, an increase in the level of the lipidated LC3 protein, and the formation of
autolysosomes. Moreover, the inhibition of autophagy affects RTA-mediated lytic gene expression and viral
DNA replication. These results suggest that RTA increases autophagy activation to facilitate KSHV lytic
replication. This is the first report demonstrating that autophagy is involved in the lytic reactivation of KSHV.
Autophagy is an intracellular catabolic mechanism and is
principally responsible for the degradation of long-lived cellu-
lar proteins and damaged organelles. The degraded products
are recycled primarily to supply nutrients when cells are un-
dergoing nutrient deficiency. The hallmark of autophagy is the
formation of double-membrane cytosolic vacuoles, called au-
tophagosomes, which sequester entire organelles and large
protein aggregates. Eventually, autophagosomes fuse with the
lysosomes to generate single-membrane vacuoles, termed au-
tolysosomes, where the contents subsequently are degraded
and/or recycled by lysosomal hydrolases (34). This intracellular
degradation system is tightly regulated by a family of genes,
known as autophagy-related genes (Atg), which were described
initially in yeast (27, 62). In higher eukaryotes, a number of Atg
genes homologous to yeast Atg have been shown to be essential
for autophagy formation in various eukaryotic systems (34). In
addition to the classical homeostatic function, autophagy plays
an important role in multiple biological processes, including
differentiation, development, anti-aging, and cell death, and
aberrant autophagy is implicated in a number of human dis-
eases, such as cancer, neurodegeneration, and certain muscu-
lar myopathies (22, 35, 49).
The function of autophagy in cellular defense is to remove
invading pathogens, including viruses; however, some patho-
gens have developed strategies to adopt the host autophagic
machinery for their own survival and replication (26, 33). In-
fection by the single-stranded DNA virus B19 parvovirus in-
duces autophagy to prolong the survival of the infected cells
(42). The infection of the positive-stranded RNA viruses, such
as poliovirus, coxsackievirus, and dengue virus, induces dou-
ble-membrane vesicles resembling autophagosomes to in-
crease viral RNA replication (21, 32, 53, 61). The induction of
autophagosomes by poliovirus also is proposed to play a role in
the nonlytic mechanism for poliovirus release (21, 25). Autoph-
agy is also an important innate immunity mechanism that some
viruses can evade by subverting or hijacking the autophagy
process. For example, herpes simplex virus type 1 (HSV-1)
ICP34.5 targets the mammalian autophagy protein Beclin 1 to
block the host autophagy machinery to induce neurovirulence
(43). Also, ICP34.5 can block autophagy through interference
with the phosphorylation of eIF2 (eukaryotic translation ini-
tiation factor 2 alpha) by PKR (54). Epstein-Barr virus (EBV)
latent membrane protein 1 (LMP1), which is required for the
proliferation of infected B cells, utilizes autophagic degrada-
tion to limit its accumulation in EBV-infected B cells (30). The
human immunodeficiency virus type I (HIV-1) envelope gly-
coprotein-mediated killing of uninfected CD4 T cells was
found to be dependent on the autophagy machinery and may
be involved in the pathogenesis of AIDS (14, 15). Overall,
these studies present a complex picture defining the role of
autophagy in viral pathogenesis, but this effect is both virus and
host strain specific.
Kaposi’s sarcoma-associated herpesvirus (KSHV) belongs to
the gammaherpesvirus family and is associated with Kaposi’s
sarcoma and other malignancies, such as primary effusion lym-
phoma (PEL) and multicentric Castleman’s disease (MCD).
As in all herpesviruses, KSHV exhibits two phases in its rep-
lication cycle, latent and lytic phases. During latency, KSHV is
capable of evading the immune surveillance to persist in host
cells without viral production; however, infectious viral parti-
cles can be produced and released after the induction of lytic
reactivation from latency as a result of stress or chemical stim-
uli, such as phorbol esters or sodium butyrate (4, 5, 39, 40, 46).
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In addition to in vitro stimuli, an immediate-early KSHV gene,
ORF50, encodes the replication and transcription activator
(RTA), which has the ability to initiate the entire lytic reacti-
vation cascade (38). RTA is a typical transcriptional factor
containing an N-terminal DNA-binding domain and a C-ter-
minal activation domain. RTA can trigger KSHV lytic reacti-
vation via the transcriptional activation of a number of viral
lytic promoters (2, 6, 8, 11–13). However, for the virus to
regulate between lytic replication and latency, the transactiva-
tion function of RTA can be suppressed by various viral and
cellular repressors to limit the extent of lytic replication to
return to latency (3, 17, 18, 20, 29, 58, 63–65). To overcome this
suppression to facilitate lytic reactivation, viral RTA has the
ability to promote the degradation of the repressors by mod-
ulating the ubiquitin-proteasome pathway (16, 66, 67). Since a
cellular regulatory mechanism is adopted by KSHV to switch
between the lytic cycle and latency and various viruses have
adopted the autophagy pathway to regulate their replication, it
will be of interest to determine whether KSHV replication also
involves the autophagy pathway. In this study, we found that
the activation of autophagy is enhanced during KSHV lytic
reactivation, and the viral lytic replication inducer RTA is
involved in this activation.
MATERIALS AND METHODS
Cells, viruses, plasmids, and reagents. Human 293T cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Carlsbad CA) sup-
plemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT), 100 g/ml
penicillin-streptomycin (Mediatech) at 37°C with 5% CO2. For starvation exper-
iments, the cells were washed with 1 phosphate-buffered saline (PBS) three
times and incubated in 1 Earle’s balanced solution (Invitrogen) for 90 min.
BCBL-1 is a KSHV-positive primary effusion lymphoma cell line, and BJAB is a
KSHV-negative cell line derived from Burkitt’s lymphoma. TRExBCBL1-RTA
and TRExBJAB-RTA, both carrying a tetracycline-inducible RTA gene, were
provided by Jae Jung (University of Southern California, Los Angeles, CA) (41).
These B cells were grown in RPMI 1640 medium (Gibco BRL) supplemented
with 10% FBS and 100 g/ml penicillin-streptomycin at 37°C with 5% CO2. Vero
cells infected by rKSHV.219 virus were provided by Jeffrey Vieira (University of
Washington, Seattle, WA) (57). The cells were grown in DMEM supplemented
with 10% FBS, 100 g/ml penicillin-streptomycin, and 6 g/ml puromycin
(Sigma) at 37°C with 5% CO2. Bac50, a recombinant baculovirus expressing
KSHV RTA, also was provided by Jeffrey Vieira for the induction of KSHV lytic
replication as described earlier (57). To establish the knockdown cell line, Beclin
1 (BECN 1) and scrambled negative control (Scramble) shRNA plasmids were
purchased from Origene and were transfected into TRExBCBL1-RTA cells
using the nucleofector system (Lonza), and the transfected cells were selected by
puromycin.
RTA expression plasmid (pCMVtagORF50), which encodes Flag-tagged full-
length RTA, has been described previously (59). mRTA contains truncated RTA
(amino acid 1 to 527), which was cloned in the pCMVtag-2A vector. Plasmid
pGFP-LC3, encoding the green fluorescent protein (GFP)-tagged rat LC3 gene,
was obtained from N. Mizushima (Tokyo Medical and Dental University, Japan)
(23).
Bafilomycin A1, 3-methyladenine (3-MA), sodium butyrate (NaB), and 12-O-
tetradecanoylphorbol-13-acetate (TPA) were purchased from Sigma.
Flow-cytometric analysis and cell viability assay. The rKSHV.219-infected
Vero cells were infected with Bac50 virus for 4 h and treated with sodium
butyrate (Sigma) for 24 h and/or 3-methyladenine (Sigma) at the indicated time
points. The cells were harvested and analyzed with a FACSCalibur flow cytom-
eter using the Cell Quest software (BD Biosciences). rKSHV.219-infected Vero
cells were treated with 3-MA for 24 and 40 h, and their viability was measured
by a cell viability analyzer (Vi-cell; Beckman).
Western blot analysis. Cells were harvested, and the cell pellets were resus-
pended in M-PER buffer (Pierce) containing protease inhibitor cocktail (Pierce)
at 4°C for 20 min, followed by centrifugation at 10,000 rpm for 5 min at 4°C. Cell
lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and then transferred to a polyvinylidene difluoride
(PVDF) membrane (GE Health Care), followed by incubation with specific
antibodies as described previously (65). LC3 antibody was purchased from Ab-
cam Inc., and BECN1 antibody against human Beclin 1 was purchased from
Santa Cruz Biotechnology. For protein loading controls, anti-tubulin antibody
and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody were
purchased from Santa Cruz Biotechnology. For the detection of His- and Flag-
tagged proteins, the horseradish peroxidase (HRP)-conjugated anti-6His an-
tibody and mouse anti-Flag M2 monoclonal antibody were purchased from
Clontech and Stratagene. Anti-K8a antibody was purchased from Novous, and
anti-RTA antibody was provided by Luwen Zhang (University of Nebraska-
Lincoln). The band intensities were measured by using the NIH image software
ImageJ.
Confocal microscopy and LysoTracker red and 4,6-diamidino-2-phenylin-
dole (DAPI) staining. Quantitative GFP-LC3 autophagy assays were per-
formed in 293T and TRExBJAB-RTA cells transfected with GFP-LC3 ex-
pression plasmids. The 293T cells were grown in 35-mm coverslip-bottom dishes
(BD Biocoat) and cultured under the conditions indicated. To express RTA
proteins in cells, RTA expression plasmid (pCMVtagORF50) was cotransfected
into 293T cells along with GFP-LC3 expression plasmids. To induce RTA ex-
pression in TRExBJAB-RTA cells, the cells were treated with doxycycline after
the transfection of GFP-LC3. For TRExBJAB-RTA, cells were fixed using 4%
paraformaldehyde in PBS for 15 min at room temperature and then washed with PBS
twice and deposited onto a slide for confocal microscopy visualization. A series of optical
images were obtained with an Olympus FV500 confocal system on an inverted micro-
scope, using the 488-nm laser line (522-nm emission) for GFP detection.
Cells containing 3 GFP-LC3 dots were defined as autophagy-positive cells.
The number of cells with GFP-LC3 punctate dots relative to all GFP-LC3-
positive cells was counted (a minimum of 200 GFP-LC3-positive cells were
counted in total for each experiment) and is presented as percentages.
For LysoTracker red staining, the cells were treated with 1 M LysoTracker
Red DND-99 (Invitrogen) at 37°C for 30 min. Depending on the experiments,
293T cells were starved in Earle’s balanced salts solution (EBSS; Gibco-BRL) for
90 min in the presence of LysoTracker red dye. Cells then were fixed in 3.7%
formaldehyde, and nuclei were stained with DAPI (Calbiochem) for 10 min.
Three-channel, optical images (DAPI, GFP, and Lysotracker red) were collected
using the sequential scanning mode (405-, 488-, and 543-nm excitation; 450-,
522-, and 595-nm emission, respectively) of the Olympus FV500 confocal system.
Transmission electron microscopy (TEM). 293T cells were transfected with
pCMVtagORF50 or pCMVtag (control) plasmids and harvested at 24 h post-
transfection. Cell pellets were washed with 1 PBS once and fixed with 2.5%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 h at room temperature.
Fixed cells were dehydrated through a graduated ethanol series and embedded
in Epon 812 (Electron Microscopic Sciences, Fort Washington, PA). Thin sec-
tions (60 to 80 nm) were stained with uranyl acetate and lead citrate and
observed under a transmission electron microscope (Hitachi H7500-I). A series
of ultrastructural images were collected with a bottom-mount digital camera for
the confirmational analysis of autophagy.
Real-time RT-PCR. Total RNA was isolated using an RNA mini kit (Qiagen)
using the protocol recommended by the supplier. RNA samples were digested
with DNase (Invitrogen) to remove residual DNA. Real-time reverse transcrip-
tion-PCR (RT-PCR) was carried out using an iScript one-step RT-PCR kit with
SYBR green. The primers used for the mRNA quantitation were ORF57 (5-G
CATATTTGGTAGCGATGGG-3 [forward] and 5-GGGATAGTTAGGACA
AAGGC-3[reverse]) and K8.1 (5-CGCTCCTAATCCTATGCCTT-3 [for-
ward] and 5-CTGATAAACCTGTCCACTCC-3 [reverse]). All reactions were
performed in duplicate. For the calculation of the relative mRNA amount from
quantitative real-time PCR, the CT (threshold cycle) value of each viral gene was
normalized by the CT value of GAPDH, and the normalized CT values from
samples were compared to those of the control samples (untreated).
Viral DNA copy number. The intracellular viral DNA was extracted from
TRExBCBL1-RTA cells using a genomic DNA purification kit (Gentra). The
viral DNA was quantified by real-time PCR using iQ SYBR green supermix
(Bio-Rad). To generate a standard curve for cycle thresholds versus genomic
copy numbers, the pCMVtagORF50 plasmid was serially diluted to known con-
centrations. Primers for the amplification of the ORF50 gene were 5-CAAAC
CCCATCCCAACAT-3 and 5-AGTAATCACGGCCCCTT-3. The DNA copy
number was calculated using Bio-Rad iCycler software (version 3.1).
RESULTS
An autophagy inhibitor suppresses KSHV lytic reactivation.
To investigate whether autophagy affects KSHV lytic reactiva-
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FIG. 1. Defective autophagy reduces KSHV lytic reactivation. (A) rKSHV.219 latently infected Vero cells were infected with Bac50 virus and
treated with sodium butyrate (NaB), and cells with lytic replication were detected by RFP expression observed under a fluorescence microscope.
Cells were also either untreated or treated with 3-methyladenine (3-MA) for 24 or 40 h. The GFP fluorescence and phase-contrast micrographs
are showed in parallel. (B) The RFP signal expressed from cells as described for panel A were measured by flow cytometry. The results shown are
based on the averages from three separate experiments. Results are expressed as means  standard deviations. Asterisks indicate P  0.05 (Student’s
t test). (C) The autophagic inhibitor 3-MA is not toxic to cells. A cell viability analyzer (Vi-cell; Beckman) was used to measure cell viability.
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tion, a specific autophagy inhibitor, 3-methyladenine (3-MA),
was used to suppress the autophagic pathway in rKSHV.219
latently infected Vero cells, and cells were examined by mi-
croscopy and flow cytometry (48). Vero cells were latently
infected by a recombinant green fluorescent protein (GFP)-red
fluorescent protein (RFP) double-labeled rKSHV.219 virus,
which constitutively expresses GFP. Upon the induction of
lytic reactivation, cells will express RFP under the control of
the lytic PAN promoter (57). It had been shown that the
highest number of cells expressing lytic proteins can be in-
duced by treatment with sodium butyrate (NaB) and the in-
fection of RTA expressing baculovirus Bac50 (57). Therefore,
we followed this protocol for the induction of KSHV lytic
reactivation in rKSHV.219-infected Vero cells. Figure 1A
shows that the number of cells harboring reactivated KSHV at
40 h postinduction was higher than that at 24 h postinduction.
However, in the presence of the autophagy inhibitor 3-MA, the
number of KSHV-reactivated cells was reduced compared to
that of the untreated control. There was a 60% reduction of
RFP-expressing cells at 24 h after 3-MA treatment and a 33%
reduction at 40 h, as determined by flow cytometry (Fig. 1B).
The cells expressing GFP were not affected by 3-MA treatment
due to the similar percentage of cells expressing GFP in the
absence and presence of 3-MA (89.2 and 90.2%, respectively;
data not shown). In addition, similar cell viabilities were ob-
served in both 3-MA-treated and untreated cells, indicating
that the reduction in viral reactivation was not due to the toxic
effect of 3-MA (Fig. 1C). These results demonstrated that
3-MA reduces KSHV lytic reactivation, this reduction likely is
due to its effect on autophagy, and the effect is most prominent
during the early phase of lytic reactivation.
The activation of autophagy is enhanced during KSHV lytic
replication. The conversion of microtubule-associated protein
1 light chain 3 (LC3) is a hallmark of autophagy and has been
used to detect autophagy activation. In quiescent cells, LC3
protein is expressed in the cytoplasm as a precursor protein
known as LC3-I (18-kDa). When autophagy is activated, LC3-I
can be conjugated to phosphatidylethanolamine (PE) by a
ubiquitination-like reaction to generate a lipidated species
termed LC3-II (16-kDa) that is associated with inner and outer
membranes of autophagosomes (19, 24). Therefore, to exam-
ine the status of the autophagy activation during KSHV lytic
replication, LC3 proteins were examined by the Western blot
analysis of KSHV-positive cells. We observed that more
LC3-II molecules were accumulated in BCBL-1 cells after 12-
O-tetradecanoylphorbol-13-acetate (TPA) and NaB treat-
ments. In addition, a time course study analyzing the cells at
different time points after chemical stimulation showed that
there was an increase in the amount of the endogenous auto-
phagic protein Beclin 1, which is known to be responsible for
the initiation of the autophagic pathway (Fig. 2A). Therefore,
the increases in the expression levels of two autophagic pro-
teins as well as the presence of KSHV lytic gene product K8
after TPA and NaB stimulation indicate that the activation of
autophagy is enhanced during KSHV lytic replication.
The KSHV immediate-early gene product RTA is consid-
ered to be necessary and sufficient for KSHV lytic reactivation
(38). Therefore, to determine whether the activation of auto-
phagy also is increased during RTA-induced lytic replication,
LC3 conversion was analyzed in RTA-inducible BCBL-1 cells
(TRExBCBL1-RTA). In this cell line, RTA is integrated into
the genome of BCBL-1 cells, and its expression is regulated by
doxycycline (41). We demonstrated that the overexpression
of RTA in TRExBCBL1-RTA efficiently triggers lytic rep-
lication, as shown by the enhancement of the expression of
an early gene product, K8. Simultaneously, the accumula-
tion of LC3-II was observed upon the overexpression of
RTA in TRExBCBL1-RTA cells (Fig. 2B). These results
indicate that there is an enhancement of autophagic process
during KSHV lytic reactivation upon RTA overexpression
or treatment by chemicals.
RTA is able to enhance the autophagic process in 293T cells.
To investigate whether RTA is able to induce the autophagic
process, the presence of autophagic vacuoles was monitored
after the cotransfection of RTA and GFP-tagged LC3 expres-
sion plasmids in 293T cells. Since LC3-II is lipidated and as-
sociated with the inner and outer membrane of autophagic
vacuoles, the green fluorescent signal from GFP-LC3 can be
shifted from a diffuse cytosolic/nuclear staining to a punctate
pattern outlining the autophagic vacuoles in the cells if auto-
phagy is triggered. In cells transfected with the control GFP
vector and starved in salt buffer, no obvious green punctate
dots were observed (Fig. 3A). In contrast, green punctate dots
FIG. 2. Autophagy is enhanced during KSHV lytic reactivation.
(A) BCBL-1 cells were treated with 20 ng/ml TPA and 3 mM NaB for
the indicated time. (B) TRExBCBL1-RTA cells were treated with 1
g/ml doxycycline (Doxy) for the indicated time to induce RTA ex-
pression. Western blot analysis was performed using specific antibod-
ies as indicated. The numbers below the blots indicate the relative
amounts of LC3-II protein that were normalized by GAPDH protein.
The exposure time of the Western blots for K8 shown in panel B is 10
less than that for panel A due to the much more efficient induction of
the lytic reactivation of the TRExBCBL1-RTA cells.
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of GFP-LC3 were very distinct and found to be distributed in
the cytosol after the starvation and/or transfection of RTA
expression plasmids. Very few GFP punctate dots were seen in
GFP-LC3-transfected cells in nutrient-rich media. The per-
centage of GFP-LC3-positive cells containing green punctate
dots then was quantified, and the results are shown in Fig. 3B.
Very few cells (2%) transfected with pCMVtag vector were
found to contain GFP-LC3 dots, and as expected, the nutrition
deprivation of these cells showed an increase in cells contain-
ing GFP-LC3 dots to about 14%. Consistently with previous
reports, we also observed that the transfection of Beclin 1,
which is one of autophagic proteins that is important for au-
tophagic nucleation (36), moderately increased the number of
GFP-LC3 dot-containing cells to about 4.2%. The number of
Beclin 1-transfected cells containing GFP-LC3 punctate dots
markedly increases to about 19% upon starvation. Interest-
ingly, the overexpression of RTA in the cells by the transient
transfection of the RTA expression plasmid dramatically in-
creased the percentage of GFP-LC3 dot-containing cells
(19.9%), which was further increased to about 35% upon star-
vation. The increased number of cells containing GFP-LC3
punctate dots was found to be dependent on the presence of
RTA in a dose-dependent manner (Fig. 3C). In addition, the
ultrastructural analysis of transfected 293T cells by electron
microscopy revealed an increased prevalence of double mem-
brane-autophagic vacuoles in the cytoplasm of the RTA-trans-
fected cells (Fig. 4B) compared to the vector-transfected 293T
cells (Fig. 4A). To demonstrate that the RTA-mediated induc-
tion of autophagy is not an overexpression phenotype, a car-
boxyl-terminal truncated RTA plasmid (mRTA) was overex-
pressed in the 293T cells for GFP dot analysis. The expression
level of mRTA was much higher than that of the wild-type
RTA (Fig. 3D, left) but was not sufficient to enhance autoph-
agy, as indicated by the number of cells containing GFP-LC3
dots (Fig. 3D, right). To confirm that the increase in GFP-LC3
dots by RTA is due to the induction of autophagy, 3-MA was
FIG. 3. Induction of autophagic vacuoles by overexpression of
RTA. (A) Confocal microscopy of autophagic vacuoles. GFP or GFP-
LC3 plasmid was cotransfected with pCMVtag or pCMVtagORF50
(RTA) expression plasmid into 293T cells. At 22 h after transfection,
the cells were cultured either in regular medium (nutrient rich) or
buffered saline (1 Earle’s balanced solution) (starvation) for another
90 min. The phase-contrast micrograph is shown in parallel. Scale
bars  10 m. (B) Quantitation of the number of cells containing GFP
punctate dots in transfected 293T cells. GFP-LC3 was cotransfected
with pCMVtag, Beclin 1, or pCMVtagORF50 (RTA) into 293T cells,
and the cells were cultured in regular medium (nutrient rich) or buff-
ered saline (starvation). (C) Induction of autophagy by RTA in a
dose-dependent manner. An increasing concentration of RTA expres-
sion was cotransfected with GFP-LC3 into 293T cells. An autophagic
inhibitor, 3-MA, was added to the transfected cells for 3 h. The
number of cells containing green punctate dots then was quantified.
(D) The increase in the autophagy by RTA is not due to an over-
expression phenotype. GFP-LC3 was cotransfected with pCMVtag,
pCMVtagORF50 (RTA), or mutant RTA (mRTA) into 293T cells,
and the cells were cultured in regular medium. The protein expres-
sion levels of RTA and mRTA are detected by Western blotting
with anti-flag antibody as shown in the left panel. The number of
cells containing green dots is shown in the right panel. All of the
results are based on averages from three independent repeats. Re-
sults are expressed as means  standard deviations.
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added to determine whether the presence of GFP-LC3 dots
can be inhibited. Indeed, 3-MA was able to reduce GFP-LC3
dot expression even with the highest concentration of RTA
added. There was a reduction of GFP-LC3 dot-expressing cells
from 25 to 10% (Fig. 3C). To further confirm the ability of
RTA to induce the activation of autophagy, LC3 conversion
was analyzed by Western blotting. As expected, LC3-II accu-
mulation was increased either in the presence of RTA or upon
starvation (Fig. 5A). Less accumulation of LC3-II was ob-
served with the transfection of vector alone. Taken together,
these results indicate that RTA is capable of inducing autoph-
agic vacuole formation without the involvement of other viral
proteins.
RTA is capable of inducing the formation of autolysosomes.
It is well established that the fusion of autophagosomes with
lysosomes to generate autolysosomes is a critical step in the
autophagy degradation process. Moreover, autolysosomes con-
tain various lysosomal enzymes that are able to digest seques-
tered material, including LC3-II, which is associated with the
inner membrane of autophagosomes. Thus, to further deter-
mine whether RTA has the ability to stimulate the maturation
of autophagic vacuoles into degradative organelles, LC3-II ac-
cumulation was analyzed by Western blotting in the presence
of an inhibitor to prevent LC3-II degradation by lysosomal
enzymes. To prevent degradation, cells were treated with
bafilomycin A1, a specific inhibitor of vacuolar proton
ATPases. As expected, cells transfected with the control plas-
mid pCMVtag showed an increase in LC3-II due to the effect
of bafilomycin to prevent LC3-II degradation. However, the
increase in the control cells is less than that of cells transfected
with RTA. This indicates that fusion between the autophago-
somes and lysosomes was enhanced in the presence of RTA
(Fig. 5A). To further confirm this result, we assessed the pres-
ence of autolysosomes in cells by using GFP-LC3 and Lyso-
Tracker red staining, which stains for acidic organelles such as
lysosomes. Clearly, in the RTA-expressing or starved cells,
LC3 was found to be colocalized with LysoTracker red, sug-
gesting the formation of the autolysosomes (Fig. 5B). Taken
FIG. 4. TEM ultrastructural confirmation of autophagic vacuoles. 293T cells were transfected with pCMVtag (A) as a control or with
pCMVtagORF50 (RTA) (B) and were cultured under nutrient-rich conditions. Arrows indicate autophagic vacuoles. N, nucleus. Panels B1, B2,
and B3 are magnified views of autophagic vacuole structures from the boxed regions shown in panel B. M, mitochondria. Scale bars  1 m.
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together, these results indicated that RTA is able to induce
LC3 conversion and the formation of autophagosomes and
autolysosomes to mediate the induction of the autophagy deg-
radation pathway.
The enhancement of autophagy activation by RTA is cell
type independent. To further demonstrate whether RTA-in-
duced autophagic activation can be observed in lymphoma
cells, the autophagic vacuole formation and LC3 molecular
conversion were estimated in an RTA-inducible BJAB cell
line, TRExBJAB-RTA. In this cell line, the RTA gene is inte-
grated into the chromosomal DNA under the control of a
tetracycline-inducible promoter. TRExBJAB-RTA and con-
trol TRExBJAB cells first were transfected with the GFP-LC3
plasmid, and GFP-LC3 punctate dots were analyzed at the
indicated time points after doxycycline treatment. Before the
addition of doxycycline (at 0 h), both cell lines have similar
basal numbers of cells containing GFP-LC3 dots, and doxycy-
cline is unable to enhance the formation of GFP-LC3 punctate
dots in the control TRExBJAB cells without the integrated
RTA gene. In contrast, the percentage of cells containing
GFP-LC3 punctate dots was increased upon the induction of
RTA expression in the TRExBJAB-RTA cells (Fig. 6A). In
addition, the levels of the processed LC3-II proteins were
found to be enhanced upon RTA induction in the TRExBJAB-
RTA cells but remained constant in control TRExBJAB cells
(Fig. 6B). Consistently with our results obtained with 293T
cells, the increase in the autophagy activation by RTA likely is
cell type independent.
Inhibition of autophagy affects RTA-mediated lytic replica-
tion. Our findings suggest that the autophagic process can be
enhanced by RTA expression, and the inhibition of autophagy
affects KSHV lytic reactivation in infected Vero cells. There-
fore, the inhibition of autophagy may affect RTA-induced
KSHV lytic gene expression. To test this possibility, we mea-
sured the mRNA levels of early and late genes (ORF57 and
K8.1) in RTA-inducible BCBL-1 cells (TRExBCBL1-RTA) in
the presence or absence of an autophagy inhibitor (3-MA). In
the reverse transcription quantitative PCR analysis, the induc-
tion of RTA by doxycycline was able to elevate the expression
of ORF57 and K8.1 mRNA, indicating that lytic replication is
triggered. However, the suppression of autophagy by 3-MA
treatment leads to a reduction in the RTA-induced lytic gene
FIG. 5. Induction of autolysosomes by RTA. (A) Western blot analysis of LC3 in 293T cells transfected with pCMVtag or pCMVtafORF50
(RTA) and treated with bafilomycin A1 (as indicated by the letter B) or dimethylsulfoxide (DMSO) (control) for 4 h or salt buffer (as indicated
by the letter S) for 90 min. The numbers indicate the relative amounts of LC3-II protein that were normalized with the GAPDH protein.
(B) Confocal microscopy of autolysosomes. The plasmids transfected into 293T cells were as indicated. For starvation, the transfected cells were
starved for 90 min in salt buffer. Lysosomes were stained by LysoTracker red dye (red), autophagosomes were stained by GFP-LC3 (green), and
autolysosomes were stained by LysoTracker red and GFP-LC3 showing a yellow signal. The nuclei were stained with DAPI (blue). Scale bars 
10 m.
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mRNA expression of ORF57 and K8.1 (62 and 72% reduction,
respectively) (Fig. 7A). To specifically inhibit autophagy, we
employed a gene knockdown approach using shRNA against
Beclin 1, which is required for the initiation of autophagy (36).
After the transfection of shRNA plasmid in TRExBCBL-RTA
cells and puromycin selection, the reduction of Beclin 1
mRNA and protein was confirmed by reverse transcription-
quantitative PCR and Western blotting (Fig. 7B). We found
that the RTA-mediated mRNA expression of ORF57 and K8.1
were decreased by 53 and 42% reduction, respectively, in the
Beclin 1 knockdown cells (Fig. 7C). It is well known that RTA
triggers lytic gene expression to facilitate KSHV lytic replica-
tion. Thus, we also measured the viral DNA copy number in
the TRExBCBL-RTA cells with and without 3-MA treatment.
Figure 7D shows that the inhibition of autophagy by 3-MA
reduces RTA-mediated viral DNA replication (29% inhibi-
tion). Taken together, these results indicate that autophagy
positively regulates RTA-mediated lytic replication.
DISCUSSION
Autophagy has been implicated as an antiviral immune de-
fense, and a number of viruses were found to develop various
strategies to block autophagy to overcome the antiviral func-
tion of autophagy (28). However, several viruses have been
found to utilize autophagy to enhance viral replication. In our
present study, autophagy is enhanced during KSHV lytic rep-
lication and positively regulates KSHV lytic replication. It has
been shown that infections by RNA viruses, such as poliovirus,
coxsackievirus, influenza A virus, hepatitis C virus, and dengue
virus, can induce autophagy, and this induction increases viral
RNA replication and viral yield (1, 21, 32, 61, 68). Since pos-
itive-stranded RNA virus replications are associated with cy-
toplasmic membranes of infected cells (47), autophagosome-
like structures may serve as the membrane scaffold for viral
RNA replication based on the localization of their viral pro-
teins and viral RNA genome in the autophagosomes (21, 45,
60). In contrast to most RNA viruses, KSHV DNA replication
occurs in the nucleus. Therefore, it is unlikely that the auto-
phagic vacuoles in the cytoplasm can serve as sites for KSHV
replication. It has been demonstrated that KSHV adopts var-
ious cellular machineries and recruits different cellular pro-
teins to maintain latency or to initiate lytic replication (10, 66);
therefore, autophagy could be one of the cellular mechanisms
utilized by KSHV to establish an adequate environment for
lytic reactivation.
To explore the possible mechanism and biological signifi-
cance of the enhancement of autophagic activation during
KSHV lytic replication, we tested the ability of a key viral
protein, RTA, which is responsible for the initiation of KSHV
lytic reactivation, in the induction of autophagy. We observed
that RTA possesses the ability to increase the autophagic ac-
tivation, and this regulation is independent of other KSHV
viral proteins. Since RTA is a typical transcriptional factor
located in the nucleus, it is not clear how RTA can affect this
intracellular pathway, which occurs in the cytoplasm. It is
known that RTA upregulates expression of a number of intra-
cellular and viral genes (9, 37, 52, 56, 63); thus, it is possible
that RTA promotes autophagic gene expression to trigger the
autophagic pathway. A similar mechanism has been found for
hepatitis B virus (HBV), where the HBV X protein can up-
regulate Beclin 1 mRNA and protein levels to activate auto-
phagy in hepatocytes (55). Therefore, the relationship between
RTA and autophagy-related protein expression needs to be
further investigated.
In the classic autophagic pathway, portions of cytoplasm are
sequestered to form the double-membrane vacuoles, autopha-
gosomes. Subsequently, autophagosomes fused with lysosomes
to become autolysosomes, where the degradation process oc-
curs. However, there are two reports showing the blockage of
autolysosomal maturation by hepatitis C virus and coxsackievi-
rus B3, even though the induction of autophagosome-like
structures can be observed during their infections, suggesting
that the degradation function of autophagy is blocked by hep-
atitis C virus and coxsackievirus B3 (51, 61). From our results,
we found that the overexpression of RTA can enhance both
autophagosomes and autolysosome formation. There was an
enhancement of GFP-LC3 and lysosomal staining in the pres-
ence of RTA, which are similar to those observed during star-
vation. In addition, the increase in LC3-II protein level can be
observed in RTA-expressing cells treated with bafilomycin A1,
suggesting that RTA is able to induce the autophagy degrada-
tion process. A number of cellular and viral proteins have been
shown to interfere with the RTA-mediated transcription of
lytic genes to maintain KSHV latency (3, 18, 20, 29, 58, 63–65);
hence, the induction of autophagy by RTA to degrade these
repressor proteins may be a mechanism to enable the virus to
initiate lytic replication. Since RTA has been shown to pro-
mote protein degradation through the proteasome degrada-
tion pathway (16, 66, 67), it is possible that RTA also adopts
FIG. 6. Enhancement of autophagy by RTA in B cells. (A) Induc-
tion of autophagic vacuoles by RTA. After transfection with GFP-LC3
plasmids, TRExBJAB and TRExBJAB-RTA cells were treated with
doxycycline for the indicated time. The number of cells containing
green punctate dots then was quantified. The results are from the
averages from three independent experiments and are expressed as
means  standard deviations. (B) LC3 was analyzed by the Western
blot analysis of TRExBJAB and TRExBJAB-RTA cells treated with
doxycycline for the indicated time. The numbers shown below the blots
indicate the relative amounts of LC3-II protein, which were normal-
ized with the GAPDH protein.
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the autophagy degradation machinery for the clearance of cel-
lular or viral transcriptional repressors to lead to KSHV lytic
replication. Therefore, further studies need to be conducted to
demonstrate this possibility.
Currently, very little information is available regarding the
roles of autophagy on herpesvirus infection. Autophagy can be
an antiviral defense against HSV and HCMV (human cyto-
megalovirus) infection (7, 43, 44), but autophagy also could be
an advantage for viral infection, as in the case of EBV, which
uses autophagy to regulate viral LMP-1 expression (30). In our
study, we have shown that KSHV RTA may play a role in
inducing autophagy to enhance lytic replication; nevertheless,
two other KSHV proteins, vFLIP (31) and vBcl2 (50), have
been reported to possess antiautophagic function. It is possible
that KSHV can either enhance or suppress autophagy during
different phases of infection and is dependent upon the expres-
sion of various viral and cellular proteins involved. Thus, the
roles of autophagy seem to differ among different viruses, and
the regulation of autophagy may involve various viral and cel-
lular proteins, as in the case of KSHV. How these various
FIG. 7. Defective autophagy reduces RTA-mediated lytic replication. (A) Inhibition of autophagy by 3-MA affects RTA-mediated lytic gene
expression. TRExBCBL1-RTA cells were treated with different combinations of doxycycline (Doxy) and 3-MA. ORF57 and K8.1 mRNA were
quantified by real-time PCR. (B) Quantitative real-time PCR and Western blot analysis detected the mRNA and protein levels of Beclin 1 from
scrambled negative (Scramble) and Beclin 1 (BECN 1) knockdown BCBL1-RTA cells. (C) Inhibition of autophagy by the knockdown of Beclin
1 reduces RTA-mediated lytic gene expression. ORF57 and K8.1 mRNA levels from scrambled negative (Scramble) and Beclin 1 (BECN 1)
knockdown BCBL1-RTA cells with or without doxycycline (Doxy) treatment were quantified by real-time PCR. (D) Inhibition of autophagy
reduces viral DNA replication. Cellular viral DNA copy number from TRExBCBL1-RTA cells with different combinations of 3-MA and
doxycycline (Doxy) was quantified by real-time PCR. All of the results are averages from three independent experiments. Results are expressed
as means  standard deviations.
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KSHV proteins function to regulate autophagy in infected cells
during various phases of the viral replication cycle needs to be
further determined. In conclusion, our study shows that the
activation of autophagy is enhanced during KSHV lytic reac-
tivation, induced either by chemical stimuli or by RTA. RTA is
able to activate the entire process of autophagy. The inhibition
of autophagy diminishes RTA-mediated lytic gene expression
and reduces KSHV lytic replication, indicating that autophagy
is involved in KSHV lytic replication.
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